Consumer Goods » Leisure & Travel Goods | Valeritas Holdings Inc.

Valeritas Holdings Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
3.70
18,097.00
19,550.00
20,245.00
26,398
Cost of Goods Sold (COGS) incl. D&A
1.80
14,237.00
12,606.00
12,080.00
13,974
Gross Income
1.90
3,860.00
6,944.00
8,165.00
12,424
SG&A Expense
62.70
51,203.00
38,323.00
49,722.00
54,514
EBIT
60.70
-
31,379.00
41,557.00
42,090
Unusual Expense
-
3,535.00
2,943.00
3,490.00
-
Non Operating Income/Expense
-
-
106.00
9.00
27
Interest Expense
3.50
16,317.00
12,151.00
4,263.00
3,812
Pretax Income
64.30
67,195.00
46,367.00
49,301.00
45,929
Consolidated Net Income
64.30
67,195.00
46,367.00
49,301.00
45,929
Net Income
64.30
67,195.00
46,367.00
49,301.00
45,929
Net Income After Extraordinaries
64.30
67,195.00
46,367.00
49,301.00
45,929
Net Income Available to Common
64.30
67,195.00
46,367.00
51,012.00
48,129
EPS (Basic)
0.04
19.27
53.84
8.94
34.22
Basic Shares Outstanding
1,580.40
3,487.90
861.20
5,708.60
1,406.60
EPS (Diluted)
0.04
19.27
53.84
8.94
34.22
Diluted Shares Outstanding
1,580.40
3,487.90
861.20
5,708.60
1,406.60
EBITDA
60.70
45,663.00
29,338.00
39,705.00
40,826
Preferred Dividends
-
-
-
1,711.00
2,200

About Valeritas Holdings

View Profile
Address
750 Route 202 South
Bridgewater New Jersey 08807
United States
Employees -
Website http://www.valeritas.com
Updated 07/08/2019
Valeritas Holdings, Inc. engages in the development of innovative technologies to improve the health and quality of life of people. It offers products under the V-Go brand. V-Go Disposable Insulin Delivery Device, is used by patients with type 2 diabetes to maintain target blood glucose goals.